What Drives me to Detect Sepsis Earlier using AI Technology

Daniel Nichita recounts his personal sepsis journey and how it drives him to find innovative solutions for early sepsis detection
What Drives me to Detect Sepsis Earlier using AI Technology

Daniel Nichita, Beckman Coulter’s Senior Product Manager for the BARDA Sepsis Program, explains how his commitment to develop early sepsis detection tools stems from a personal story.

Like many, Daniel Nichita, MD, MS sepsis journey started with the loss of a loved one. In his case, it was his mother. Her story would have perhaps ended there, except that during the ordeal, Dr. Nichita witnessed several lapses in clinical judgment that as a trained physician, he found very troubling and simply could not ignore.

Find out what he learned through his mother’s story, and how it drove him to develop the Sepsis Clinical Guide App for delivering sepsis information to Emergency Department professionals, a journey that eventually led him to Beckman Coulter.

 

AI Technology is the key to early sepsis detection

"While it is still early, I am convinced that AI tools will one day make sepsis misdiagnosis a thing of the past and will be as common and indispensable in clinical medicine as the stethoscope is today,” Dr. Nichita concludes. “I am excited and proud to join Beckman Coulter at the forefront of this new revolution."

Learn more about solutions to detect sepsis earlier

Daniel Nichita, MD, MS.
Daniel Nichita, MD, MS.
Daniel Nichita, MD, MS is Senior Product Marketing Manager at Beckman Coulter. As product manager of the BARDA Sepsis Program, Dr. Nichita is passionate about developing innovative solutions to help detect sepsis earlier using AI technology.

Related Articles

The evolution of high-sensitivity HIV diagnostic testing

The evolution of high-sensitivity HIV diagnostic testing

High-sensitivity diagnostic immunoassay testing is vital for meeting the increased HIV testing demands and enabling earlier treatment, which may curb viral transmissions by detecting infections sooner.
New PLA Code for Monocyte Distribution Width (MDW) Marker

New PLA Code for Monocyte Distribution Width (MDW) Marker

The American Medical Association designated MDW with a PLA code. This important milestone reflects the proprietary and novel aspects of MDW as a marker of severity of infection.
What is Sensitivity vs Specificity?

What is Sensitivity vs Specificity?

Sensitivity vs specificity, PPV/NPV, and likelihood ratios are vital indicators for accurate clinical decisions. Learn the basics!